cloudfront
  • info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) | +1-214-736-7666 (US) | +1-740-994-0111 (US)
  • Sign In
  • Register

Report Detail



Pharma & HealthcareChina Anti-Infective Vaccines Market Research Report 2018

  • RnM1701561
  • |
  • 12 March, 2018
  • |
  • Global
  • |
  • 102 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

China Anti-Infective Vaccines Market Research Report 2018
1 Anti-Infective Vaccines Overview
1.1 Product Overview and Scope of Anti-Infective Vaccines
1.2 Classification of Anti-Infective Vaccines by Product Category
1.2.1 China Anti-Infective Vaccines Sales (K Units) Comparison by Type (2013-2025)
1.2.2 China Anti-Infective Vaccines Sales (K Units) Market Share by Type in 2017
1.2.3 Anti-Bacterial Vaccines
1.2.4 Anti-Viral Vaccines
1.3 China Anti-Infective Vaccines Market by Application/End Users
1.3.1 China Anti-Infective Vaccines Sales (K Units) and Market Share Comparison by Applications (2013-2025)
1.3.2 Typhoid
1.3.3 Influenza
1.3.4 Other
1.4 China Anti-Infective Vaccines Market by Region
1.4.1 China Anti-Infective Vaccines Market Size (Million USD) Comparison by Region (2013-2025)
1.4.2 South China Anti-Infective Vaccines Status and Prospect (2013-2025)
1.4.3 East China Anti-Infective Vaccines Status and Prospect (2013-2025)
1.4.4 Southwest China Anti-Infective Vaccines Status and Prospect (2013-2025)
1.4.5 Northeast China Anti-Infective Vaccines Status and Prospect (2013-2025)
1.4.6 North China Anti-Infective Vaccines Status and Prospect (2013-2025)
1.4.7 Central China Anti-Infective Vaccines Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Anti-Infective Vaccines (2013-2025)
1.5.1 China Anti-Infective Vaccines Sales (K Units) and Growth Rate (%)(2013-2025)
1.5.2 China Anti-Infective Vaccines Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 China Anti-Infective Vaccines Market Competition by Players/Manufacturers
2.1 China Anti-Infective Vaccines Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Anti-Infective Vaccines Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Anti-Infective Vaccines Average Price (USD/Unit) by Players/Manufacturers (2013-2018)
2.4 China Anti-Infective Vaccines Market Competitive Situation and Trends
2.4.1 China Anti-Infective Vaccines Market Concentration Rate
2.4.2 China Anti-Infective Vaccines Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Anti-Infective Vaccines Manufacturing Base Distribution, Sales Area, Product Types

3 China Anti-Infective Vaccines Sales and Revenue by Region (2013-2018)
3.1 China Anti-Infective Vaccines Sales (K Units) and Market Share by Region (2013-2018)
3.2 China Anti-Infective Vaccines Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Anti-Infective Vaccines Price (USD/Unit) by Regions (2013-2018)

4 China Anti-Infective Vaccines Sales and Revenue by Type/ Product Category (2013-2018)
4.1 China Anti-Infective Vaccines Sales (K Units) and Market Share by Type/ Product Category (2013-2018)
4.2 China Anti-Infective Vaccines Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Anti-Infective Vaccines Price (USD/Unit) by Type (2013-2018)
4.4 China Anti-Infective Vaccines Sales Growth Rate (%) by Type (2013-2018)

5 China Anti-Infective Vaccines Sales by Application (2013-2018)
5.1 China Anti-Infective Vaccines Sales (K Units) and Market Share by Application (2013-2018)
5.2 China Anti-Infective Vaccines Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 China Anti-Infective Vaccines Players/Suppliers Profiles and Sales Data
6.1 Teva Pharmaceutical Industries
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Anti-Infective Vaccines Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Teva Pharmaceutical Industries Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.1.4 Main Business/Business Overview
6.2 Emergent Biosolutions
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Anti-Infective Vaccines Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Emergent Biosolutions Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.2.4 Main Business/Business Overview
6.3 Sanofi Pasteur
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Anti-Infective Vaccines Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Sanofi Pasteur Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.3.4 Main Business/Business Overview
6.4 GSK
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Anti-Infective Vaccines Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 GSK Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.4.4 Main Business/Business Overview
6.5 Merck
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Anti-Infective Vaccines Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Merck Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.5.4 Main Business/Business Overview
6.6 CSL Limited
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Anti-Infective Vaccines Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 CSL Limited Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.6.4 Main Business/Business Overview
6.7 Astrazeneca
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Anti-Infective Vaccines Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Astrazeneca Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.7.4 Main Business/Business Overview
6.8 Protein Sciences Corporation
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Anti-Infective Vaccines Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Protein Sciences Corporation Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.8.4 Main Business/Business Overview
6.9 Pfizer
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Anti-Infective Vaccines Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Pfizer Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.9.4 Main Business/Business Overview
6.10 Serum Institute Of India
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Anti-Infective Vaccines Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Serum Institute Of India Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.10.4 Main Business/Business Overview

7 Anti-Infective Vaccines Manufacturing Cost Analysis
7.1 Anti-Infective Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anti-Infective Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Anti-Infective Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anti-Infective Vaccines Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 China Anti-Infective Vaccines Market Size (Sales and Revenue) Forecast (2018-2025)
11.1 China Anti-Infective Vaccines Sales (K Units), Revenue (Million USD) Forecast (2018-2025)
11.2 China Anti-Infective Vaccines Sales (K Units) Forecast by Type (2018-2025)
11.3 China Anti-Infective Vaccines Sales (K Units) Forecast by Application (2018-2025)
11.4 China Anti-Infective Vaccines Sales (K Units) Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The global Anti-Infective Vaccines market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Anti-Infective Vaccines development status and future trend in China, focuses on top players in China, also splits Anti-Infective Vaccines by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
Teva Pharmaceutical Industries
Emergent Biosolutions
Sanofi Pasteur
GSK
Merck
CSL Limited
Astrazeneca
Protein Sciences Corporation
Pfizer
Serum Institute Of India

Geographically, this report splits the China market into six regions,
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Anti-Bacterial Vaccines
Anti-Viral Vaccines

On the basis of the end users/application, this report covers
Typhoid
Influenza
Other

If you have any special requirements, please let us know and we will offer you the report as you want.



REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,400.00
$6,800.00
2,283.10
4,566.20
3,128.68
6,257.36
411,876.00
823,752.00
225,465.56
450,931.12
Add To Cart Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report